We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of BIOL yet.

BIOL Hedge Fund Activity: Q1 2026 in Review

1 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q1 2026, worth a combined $1 — unchanged from a quarter earlier.

Fund positioning in BIOL was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Biolase, Inc. (BIOL) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $1 of Biolase, Inc. stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Biolase, Inc. positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.